New research shows the lung microbiome in patients with post-COVID residual lung changes is similar to healthy lungs and distinct from pulmonary fibrosis, offering insights into recovery and long-term lung health.
Many people who had COVID-19 are left with residual lung changes – areas of the lung that look abnormal on scans – even months after infection. Experts have wondered whether these changes might lead to long-term lung damage, similar to conditions like idiopathic pulmonary fibrosis (IPF).
A new study from the UK Interstitial Lung Disease (UKILD) consortium and the POSTCODE team investigated whether the lung microbiome (bacteria living in our airways) might play a role in these post-COVID lung changes. Breathing Matters-funded researchers contributed to this study.
Using advanced testing on lung fluid samples from patients about a year after COVID-19 infection, researchers compared their lung bacteria with people who have IPF, fibrotic hypersensitivity pneumonitis (fHP), and healthy volunteers.
Key Findings:
- Healthy microbiome: People with post-COVID lung changes had a lung microbiome similar to healthy individuals.
- Different from fibrotic disease: Their lung bacteria were clearly different from those in IPF, which is associated with harmful changes in the microbiome.
- No link to severity: The types or amounts of bacteria did not seem to influence the severity of lung changes or how well patients recovered.
- Dominant bacteria: Some bacteria like Streptococcus were slightly more abundant, but this did not affect recovery.
What This Means for Patients:
- Good news: Post-COVID lung changes do not appear to be caused by harmful bacterial shifts in the lungs.
- No major long-term infection risk: The microbiome is not likely contributing to lung damage after COVID-19.
- Hope for recovery: This supports the idea that most post-COVID lung changes may gradually improve over time without the complications seen in serious fibrotic diseases, seen in IPF.
Next Steps in Research:
Researchers recommend continued monitoring and long-term imaging studies to track lung recovery, but this study suggests that bacterial imbalance is not a driver of post-COVID lung problems.
Conclusion:
If you are living with lingering lung changes after COVID-19, this research is reassuring – your lung bacteria are likely healthy, and your recovery may follow a natural course. Ongoing research will continue to explore the best ways to support lung health after COVID-19.
Full article: ERJ Open Research 2025 11(3): 00826-2024
[Posted February 2026]
Recent Articles
- Life after tuberculosis
- March 2026 Newsletter
- Living with Bronchiectasis Community Days 2026
- Brinsupri™: First medicine licensed for bronchiectasis in the UK
- PET scans offer hope for SSc-ILD patients
- Post-COVID lung microbes stay healthy
- Shedding light on IPF: neutrophils’ hidden role
- Dr Wilson Fox: a 19th century pioneer in pulmonary fibrosis
- New research offers hope for IPF
- Christmas 2025 Newsletter
- A New Year message to our supporters
- A: What Is Pulmonary Fibrosis?
- B: PF versus IPF
- C: Who is at risk from pulmonary fibrosis?
- D: Can pulmonary fibrosis be prevented?



